Spurr Robert 4
4 · Bausch Health Companies Inc. · Filed Mar 4, 2022
Insider Transaction Report
Form 4
Spurr Robert
President, Salix
Transactions
- Award
Common Shares, No Par Value
2022-03-02$24.17/sh+35,627$861,105→ 101,021 total - Award
Non-Qualified Stock Options (right to purchase)
2022-03-02+131,910→ 131,910 totalExercise: $24.17Exp: 2032-03-02→ Common Shares, No Par Value (131,910 underlying) - Sale
Common Shares, No Par Value
2022-03-02$23.37/sh−1,595$37,275→ 65,394 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 16, 2021.
- [F2]Represents the award of restricted share units ("RSUs") which will vest one-third on each of the first three anniversaries following the date of grant, subject to the reporting person's continued service. Vested RSUs are settled in common shares, no par value, of Bausch Health Companies Inc.
- [F3]The options vest in equal installments on each of the first three anniversaries of the date of grant.